Fundraising Fox

Moximed

Fremont, US · Delaware corporation · 8 known investors

Find your way into Moximed

457 people in our graph share verified history with the Moximed team — schools, employers, funds. One of them is your warm intro.

Teresa Chanunlockedknows Christopher Gleason · together at Johnson & Johnson (overlapped)
×5knows the team · via Johnson & Johnson
knows the team · via UC Santa Barbara
×4knows the team · via United States Army
knows the team · via Saint John's High School
Healthtech

Founders & leadership

AC
Anton CliffordinExecutive
JLJames Leech
James LeechinChief Financial & Strategy Officer2024–2025James Leech has worked on financial, strategic, and operational matters across the life sciences industry, including biopharmaceutical, medical device, and healthcare services sectors, with experience spanning company formation, M&A, financing, and business operations from startup through growth stages.
CGChristopher Gleason
Christopher GleasoninPresident and Chief Executive OfficerChristopher Gleason holds an MBA focused on health system partnerships and value-based care models. He has led medtech companies and military organizations, with expertise spanning medical device sales, capital equipment, and adoption of minimally invasive surgical technologies including robotic surgery and specialized procedures for ENT, urology, and spine applications.
KK
Kevin K. SidowExecutive

Board

JM
Joshua MakowerBoard directorGeneral Partner at New Enterprise Associates (NEA)
SMShahzad Malik
Shahzad MalikinBoard directorGeneral Partner at Advent Life Sciences
DV
David van MeterBoard director
MM
Matt McAvineyin𝕏Board directorPartner at New Enterprise Associates (NEA)
MW
Michael WassermanBoard director
HAHenry A. Plain
Henry A. PlainBoard directorFounding Partner & Advisor at Lightstone Ventures
CS
Christopher ShenBoard director
RK
Robert K. AndersonBoard director

Investors · 8

Lightstone VenturesPortola Valley
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Runway Growth CapitalMenlo Park · $10M – $150M
Advent Life Sciencesreported · 3 sourcesLondonvia Shahzad Malik · board
Future FundreportedLondon
GBS Venture Partners Ltd.reportedMelbourne · $165K – $7.9M
Gilde HealthcarereportedUtrecht · $1.1M – $55M
Vertex Ventures HCreportedSingapore · $500K – $10M

Reported raises · per SEC filings

Form D private placements

$132M disclosed across 3 of 5 rounds · 2015–2024

▶$62.7MraisedAug 2024 · 35 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David AmersonDirector
  • Joshua MakowerDirector
  • Shahzad MalikDirector
  • David van MeterDirector
  • Matt McAvineyDirector
  • Anton CliffordExecutive Officer
  • James LeechExecutive Officer
  • Michael WassermanDirector
  • Christopher GleasonExecutive Officer
Offering amount
$91M
Amount sold
$62.7M
Minimum investment
$1
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$49.5MraisedMar 2017 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Arthur FrankenDirector
  • Robert K. AndersonDirector
  • Dan MurrayExecutive Officer
  • Henry A. PlainDirector
  • Robert W. CroceDirector
  • Joshua MakowerDirector
  • Christopher ShenDirector
  • Ryan DrantDirector
  • Kevin K. SidowExecutive Officer, Director
Offering amount
$51.5M
Amount sold
$49.5M
Minimum investment
$1
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.7MraisedMay 2015 · 104 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Henry A. PlainDirector
  • Christopher ShenDirector
  • Kevin K. SidowExecutive Officer, Director
  • Robert W. CroceDirector
  • Robert K. AndersonDirector
  • Arthur FrankenDirector
  • Joshua MakowerDirector
  • Ryan DrantDirector
Offering amount
$37.6M
Amount sold
$19.7M
Minimum investment
$1
First sale
Apr 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Moximed went on to found or lead other companies.

Ted LamsonCommercial Council MemberFounded NeoTractEb BrightConsultant General Counsel and VP, Intellectual PropertyFounded Revelle Aesthetics

Competitors · 1

by search overlap
Kinexmedical21 shared keywordsKinex Medical is an orthopedic specialty medical equipment company that delivers durable medical equipment and orthotics for post-acute and in-home rehabilitation. The company handles product fitting, billing, collections, and payer coordination while monitoring patient progress and offering telehealth rehabilitation products.

Companies competing with Moximed for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Moximed Completes $91M Series D Financingfinsmes.com · Aug 2024Moximed Series D Funding Raises $91M - Medical Devices Industry News - Zenopa USzenopa.com · Aug 2024Moximed Raises $40M for Knee OA Deviceryortho.com · Sep 2022Moximed Raises $40 Million to Advance World’s First Implantable Shock Absorber for Knee Osteoarthritis - Moximedmoximed.com · Aug 2022Moximed Raises $33 Million for Knee Shock Absorber | Orthopedics This Weekorthotw.com · May 2015Moximed Raises $33M in Funding - FinSMEsfinsmes.com · May 2015

Frequently asked questions

Who are Moximed's investors?
Moximed's investors include Lightstone Ventures, New Enterprise Associates (NEA), Runway Growth Capital, Advent Life Sciences, Future Fund, GBS Venture Partners Ltd., Gilde Healthcare, Vertex Ventures HC.
How much funding has Moximed raised?
Moximed has disclosed $132M raised across 3 of its 5 known rounds.
Where is Moximed headquartered?
Moximed is headquartered in Fremont, US.